According to the association between liver injury and pregnancy, liver diseases during pregnancy can be classified as pregnancy-specific liver diseases and liver diseases with pregnancy. Pregnancy-specific liver diseases refer to the liver diseases that only occur during pregnancy, while liver diseases with pregnancy refer to pregnancy with previous liver diseases. Due to the particularity of maternal and fetal health during pregnancy, the diagnosis and treatment of liver diseases during pregnancy is challenging for both obstetricians and hepatologists. Rapid identification, diagnosis, and treatment of related diseases during pregnancy are very important for the prognosis of the mother and the fetus. This article summarizes and reviews the research advances in the epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prognosis of liver diseases during pregnancy, in order to provide a reference for more clinicians.

Great achievements have been made in the treatment of liver cancer in recent years. Inflammation plays an important role in the development and progression of liver cancer, while aspirin can exert an anti-inflammatory effect. Basic and clinical studies have found that aspirin can inhibit the development and progression of liver cancer, assist in the comprehensive treatment of liver cancer, and exert an anticancer effect together with other drugs. Aspirin has low costs and is easy to access, and its potential in the adjuvant therapy for liver cancer has attracted great attention; however, there are still many problems and confusions in the application of aspirin in clinical practice. This article summarizes and reviews the recent research advances in aspirin in the prevention and treatment of liver cancer, the problems faced at present, and the future development direction, in order to improve the understanding of this field and lay a foundation for clinical application in the real world in the future.